Disclosures: Venture Capital Investments 2025/26

The following Venture Capital investments were announced during the fiscal year of 2025/26.

Tuesday, July 8, 2025   
 
3DBioFibR Inc., a leading manufacturer of advanced biopolymer fibers, has secured a venture capital investment of $1 million from Invest Nova Scotia. 
 
This investment will support 3DBioFibR as it improves operational scale through increased manufacturing capacity, operational growth, and implementation of ISO 13485 certification, including the construction of a clean room manufacturing facility. 
  
3DBioFibR Inc. is driving the adoption of biomaterials in regenerative medicine, medical devices, defence, cosmetics, and sustainable textiles. Its patented dry-spinning technology enables scalable, high-precision manufacturing of advanced biopolymer fibers—delivering superior performance at industrial scales. 
  
Invest Nova Scotia invests directly in highly innovative early-stage Nova Scotia companies addressing big challenges – alongside institutional, private sector, and angel investors from Canada and beyond. In addition to capital, Invest Nova Scotia provides hands-on business guidance, supports good governance, helps open doors to co-investors, and facilitates relationships across the start-up, technology, and venture capital ecosystems. 
  
Facts:

• Invest Nova Scotia invested $100K in 3DBioFibR Inc.’s angel round in 2020, $600K in a seed round in 2022, and made a $400K follow-on investment in 2023.
• 3DBioFibR Inc. has also received support through Invest Nova Scotia’s Early-Stage Commercialization Fund, Export Development Program, and Trade Market Intelligence service. 3DBioFibR is a tenant at The Labs at Invest Nova Scotia.
• Invest Nova Scotia manages the Nova Scotia First Fund (NSFF), a venture capital fund investing in pre-seed and seed Nova Scotia-based companies. 

Media Contact:   
Abrianna Di Pietro
Brand & Office Manager
info@3dbiofibr.com